News | February 17, 2025
Nectar Life Care launches affordable anti-diabetic range of medicines
Offers affordable, high-quality solutions for diabetes care
Offers affordable, high-quality solutions for diabetes care
Finerenone is the first drug targeting the mineralocorticoid receptor (MR) pathway to demonstrate cardiovascular benefits in a Phase III study in patients with heart failure
The safety profile of Opdualag observed in this analysis was consistent with the known profiles of nivolumab and relatlimab
Revenue up 11% to Rs 5,768 crore as compared to Rs 5,197 crore
Next-generation lens features purely refractive design, delivering uninterrupted high-quality vision with high best-in-category contrast & low-light performance
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries
_256_384.jpg)
Hikal Limited announces the completion of the US Food and Drug Administration (USFDA) inspection at its Jigani unit, Bengaluru
Wockhardt also saw its revenue from operations increased 3% to Rs. 721 crore during Q3 FY25
During the quarter, US formulations revenue decreased by 2.3% YoY to Rs. 3,671 crore.
EMBLAVEOTM is the first and only monobactam/?-lactamase inhibitor combination antibiotic therapy approved by the USFDA
Subscribe To Our Newsletter & Stay Updated
